FGFR3 is a target of the homeobox transcription factor SHOX in limb development

Human Molecular Genetics

Volumn 20, Issue 8, 2011, Pages 1524-1535

  Decker, Eva ^a   Durand, Claudia ^a   Bender, Sebastian ^a,b   Rödelsperger, Christian ^c,d   Glaser, Anne ^a   Hecht, Jochen ^c,d   Schneider, Katja U ^a   Rappold, Gudrun ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; LUCIFERASE; SHORT STATURE HOMEOBOX PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ACHONDROPLASIA; ANIMAL CELL; ARTICLE; BINDING SITE; CELL TYPE; CHICKEN; CHROMATIN IMMUNOPRECIPITATION; DYSCHONDROSTEOSIS; EMBRYO; EMBRYO DEVELOPMENT; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; LIMB BUD; LIMB DEVELOPMENT; MESENCHYME CELL; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR GENE; REGULATORY MECHANISM; REPORTER GENE;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CHICK EMBRYO; CHONDROCYTES; DOWN-REGULATION; ECTODERM; GENES, REPORTER; HINDLIMB; HOMEODOMAIN PROTEINS; HUMANS; LUCIFERASES, FIREFLY; MESODERM; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PHENOTYPE; PROMOTER REGIONS, GENETIC; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECOMBINANT PROTEINS; RNA INTERFERENCE; TRANSCRIPTION, GENETIC; WING;

EID: 79953111544     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr030     Document Type: Article

References (57)

1. Clement-Jones, M., Schiller, S., Rao, E., Blaschke, R.J., Zuniga, A., Zeller, R., Robson, S.C., Binder, G., Glass, I., Strachan, T. et al. (2000) The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum. Mol. Genet., 9, 695-702.
2. Tiecke, E., Bangs, F., Blaschke, R., Farrell, E.R., Rappold, G. and Tickle, C. (2006) Expression of the short stature homeobox gene Shox is restricted by proximal and distal signals in chick limb buds and affects the length of skeletal elements. Dev. Biol., 298, 585-596.
3. Munns, C.J., Haase, H.R., Crowther, L.M., Hayes, M.T., Blaschke, R., Rappold, G., Glass, I.A. and Batch, J.A. (2004) Expression of SHOX in human fetal and childhood growth plate. J. Clin. Endocrinol. Metab., 89, 4130-4135.
4. Marchini, A., Hacker, B., Marttila, T., Hesse, V., Emons, J., Weiss, B., Karperien, M. and Rappold, G. (2007) BNP is a transcriptional target of the short stature homeobox gene SHOX. Hum. Mol. Genet., 16, 3081-3087.
5. Marchini, A., Marttila, T., Winter, A., Caldeira, S., Malanchi, I., Blaschke, R.J., Hacker, B., Rao, E., Karperien, M., Wit, J.M. et al. (2004) The short stature homeodomain protein SHOX induces cellular growth arrest and apoptosis and is expressed in human growth plate chondrocytes. J. Biol. Chem., 279, 37103-37114.
6. Rao, E., Weiss, B., Fukami, M., Rump, A., Niesler, B., Mertz, A., Muroya, K., Binder, G., Kirsch, S., Winkelmann, M. et al. (1997) Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat. Genet., 16, 54-63.
7. Ellison, J.W., Wardak, Z., Young, M.F., Gehron Robey, P., Laig-Webster, M. and Chiong, W. (1997) PHOG, a candidate gene for involvement in the short stature of Turner syndrome. Hum. Mol. Genet., 6, 1341-1347.
8. Belin, V., Cusin, V., Viot, G., Girlich, D., Toutain, A., Moncla, A., Vekemans, M., Le Merrer, M., Munnich, A. and Cormier-Daire, V. (1998) SHOX mutations in dyschondrosteosis (Leri-Weill syndrome). Nat. Genet., 19, 67-69.
9. Shears, D.J., Vassal, H.J., Goodman, F.R., Palmer, R.W., Reardon, W., Superti-Furga, A., Scambler, P.J. and Winter, R.M. (1998) Mutation and deletion of the pseudoautosomal gene SHOX cause Leri-Weill dyschondrosteosis. Nat. Genet., 19, 70-73.
10. Schiller, S., Spranger, S., Schechinger, B., Fukami, M., Merker, S., Drop, S.L., Troger, J., Knoblauch, H., Kunze, J., Seidel, J. et al. (2000) Phenotypic variation and genetic heterogeneity in Leri-Weill syndrome. Eur. J. Hum. Genet., 8, 54-62.
11. Benito-Sanz, S., Thomas, N.S., Huber, C., Gorbenko del Blanco, D., Aza-Carmona, M., Crolla, J.A., Maloney, V., Rappold, G., Argente, J., Campos-Barros, A. et al. (2005) A novel class of pseudoautosomal region 1 deletions downstream of SHOX is associated with Leri-Weill dyschondrosteosis. Am. J. Hum. Genet., 77, 533-544.
12. Chen, J., Wildhardt, G., Zhong, Z., Roth, R., Weiss, B., Steinberger, D., Decker, J., Blum, W.F. and Rappold, G. (2009) Enhancer deletions of the SHOX gene as a frequent cause of short stature: the essential role of a 250 kb downstream regulatory domain. J. Med. Genet., 46, 834-839.
13. Jorge, A.A., Souza, S.C., Nishi, M.Y., Billerbeck, A.E., Liborio, D.C., Kim, C.A., Arnhold, I.J. and Mendonca, B.B. (2007) SHOX mutations in idiopathic short stature and Leri-Weill dyschondrosteosis: frequency and phenotypic variability. Clin. Endocrinol. (Oxf.), 66, 130-135.
14. Rappold, G., Blum, W.F., Shavrikova, E.P., Crowe, B.J., Roeth, R., Quigley, C.A., Ross, J.L. and Niesler, B. (2007) Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency. J. Med. Genet., 44, 306-313.
15. Huber, C., Rosilio, M., Munnich, A. and Cormier-Daire, V. (2006) High incidence of SHOX anomalies in individuals with short stature. J. Med. Genet., 43, 735-739.
16. Zinn, A.R., Wei, F., Zhang, L., Elder, F.F., Scott, C.I. Jr., Marttila, P. and Ross, J.L. (2002) Complete SHOX deficiency causes Langer mesomelic dysplasia. Am. J. Med. Genet., 110, 158-163.
17. Munns, C.F., Glass, I.A., LaBrom, R., Hayes, M., Flanagan, S., Berry, M., Hyland, V.J., Batch, J.A., Philips, G.E. and Vickers, D. (2001) Histopathological analysis of Leri-Weill dyschondrosteosis: disordered growth plate. Hand. Surg., 6, 13-23.
18. Evans, M.I., Zador, I.E., Qureshi, F., Budev, H., Quigg, M.H. and Nadler, H.L. (1988) Ultrasonographic prenatal diagnosis and fetal pathology of Langer mesomelic dwarfism. Am. J. Med. Genet., 31, 915-920.
19. Durand, C., Bangs, F., Signolet, J., Decker, E., Tickle, C. and Rappold, G. (2010) Enhancer elements upstream of the SHOX gene are active in the developing limb. Eur. J. Hum. Genet., 18, 527-532.
20. Sabherwal, N., Bangs, F., Roth, R., Weiss, B., Jantz, K., Tiecke, E., Hinkel, G.K., Spaich, C., Hauffa, B.P., van der Kamp, H. et al. (2007) Long-range conserved non-coding SHOX sequences regulate expression in developing chicken limb and are associated with short stature phenotypes in human patients. Hum. Mol. Genet., 16, 210-222.
21. Ottesen, A.M., Aksglaede, L., Garn, I., Tartaglia, N., Tassone, F., Gravholt, C.H., Bojesen, A., Sorensen, K., Jorgensen, N., Rajpert-De Meyts, E. et al. (2010) Increased number of sex chromosomes affects height in a nonlinear fashion: a study of 305 patients with sex chromosome aneuploidy. Am. J. Med. Genet. A, 152A, 1206-1212.
22. Ogata, T., Kosho, T., Wakui, K., Fukushima, Y., Yoshimoto, M. and Miharu, N. (2000) Short stature homeobox-containing gene duplication on the der(X) chromosome in a female with 45,X/46,X, der(X), gonadal dysgenesis, and tall stature. J. Clin. Endocrinol. Metab., 85, 2927-2930.
23. Mello, M.A. and Tuan, R.S. (1999) High density micromass cultures of embryonic limb bud mesenchymal cells: an in vitro model of endochondral skeletal development. In Vitro Cell. Dev. Biol. Anim., 35, 262-269.
24. Ahrens, P.B., Solursh, M. and Reiter, R.S. (1977) Stage-related capacity for limb chondrogenesis in cell culture. Dev. Biol., 60, 69-82.
25. Schneider, K.U., Marchini, A., Sabherwal, N., Roth, R., Niesler, B., Marttila, T., Blaschke, R.J., Lawson, M., Dumic, M. and Rappold, G. (2005) Alteration of DNA binding, dimerization, and nuclear translocation of SHOX homeodomain mutations identified in idiopathic short stature and Leri-Weill dyschondrosteosis. Hum. Mutat., 26, 44-52.
26. Blaschke, R.J., Monaghan, A.P., Schiller, S., Schechinger, B., Rao, E., Padilla-Nash, H., Ried, T. and Rappold, G.A. (1998) SHOT, a SHOX-related homeobox gene, is implicated in craniofacial, brain, heart, and limb development. Proc. Natl Acad. Sci. USA, 95, 2406-2411.
27. Rao, E., Blaschke, R.J., Marchini, A., Niesler, B., Burnett, M. and Rappold, G.A. (2001) The Leri-Weill and Turner syndrome homeobox gene SHOX encodes a cell-type specific transcriptional activator. Hum. Mol. Genet., 10, 3083-3091.
28. Gordon, C.T., Rodda, F.A. and Farlie, P.G. (2009) The RCAS retroviral expression system in the study of skeletal development. Dev. Dyn., 238, 797-811.
29. Stricker, S., Fundele, R., Vortkamp, A. and Mundlos, S. (2002) Role of Runx genes in chondrocyte differentiation. Dev. Biol., 245, 95-108.
30. Villavicencio-Lorini, P., Kuss, P., Friedrich, J., Haupt, J., Farooq, M., Turkmen, S., Duboule, D., Hecht, J. and Mundlos, S. (2010) Homeobox genes d11-d13 and a13 control mouse autopod cortical bone and joint formation. J. Clin. Invest., 120, 1994-2004.
31. Gotea, V., Visel, A., Westlund, J.M., Nobrega, M.A., Pennacchio, L.A. and Ovcharenko, I. (2010) Homotypic clusters of transcription factor binding sites are a key component of human promoters and enhancers. Genome Res., 20, 565-577.
32. Saleh, M., Rambaldi, I., Yang, X.J. and Featherstone, M.S. (2000) Cell signaling switches HOX-PBX complexes from repressors to activators of transcription mediated by histone deacetylases and histone acetyltransferases. Mol. Cell. Biol., 20, 8623-8633.
33. Svingen, T. and Tonissen, K.F. (2006) Hox transcription factors and their elusive mammalian gene targets. Heredity, 97, 88-96.
34. Zarnegar, M.A., Chen, J. and Rothenberg, E.V. (2010) Cell-type-specific activation and repression of PU.1 by a complex of discrete, functionally specialized cis-regulatory elements. Mol. Cell. Biol., 30, 4922-4939.
35. Le Clech, M., Chalhoub, E., Dohet, C., Roure, V., Fichelson, S., Moreau-Gachelin, F. and Mathieu, D. (2006) PU.1/Spi-1 binds to the human TAL-1 silencer to mediate its activity. J. Mol. Biol., 355, 9-19.
36. McEwen, D.G. and Ornitz, D.M. (1998) Regulation of the fibroblast growth factor receptor 3 promoter and intron I enhancer by Sp1 family transcription factors. J. Biol. Chem., 273, 5349-5357.
37. Shin, J.W., Min, M., Larrieu-Lahargue, F., Canron, X., Kunstfeld, R., Nguyen, L., Henderson, J.E., Bikfalvi, A., Detmar, M. and Hong, Y.K. (2006) Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis. Mol. Biol. Cell, 17, 576-584.
38. Sun, F., Chen, Q., Yang, S., Pan, Q., Ma, J., Wan, Y., Chang, C.H. and Hong, A. (2009) Remodeling of chromatin structure within the promoter is important for bmp-2-induced fgfr3 expression. Nucleic Acids Res., 37, 3897-3911.
39. Tan, C.C., Walsh, M.J. and Gelb, B.D. (2009) Fgfr3 is a transcriptional target of Ap2delta and Ash2l-containing histone methyltransferase complexes. PLoS One, 4, e8535.
40. Sayan, A.E., D'Angelo, B., Sayan, B.S., Tucci, P., Cimini, A., Ceru, M.P., Knight, R.A. and Melino, G. (2010) p73 and p63 regulate the expression of fibroblast growth factor receptor 3. Biochem. Biophys. Res. Commun., 394, 824-828.
41. Harada, D., Yamanaka, Y., Ueda, K., Tanaka, H. and Seino, Y. (2009) FGFR3-related dwarfism and cell signaling. J. Bone Miner. Metab., 27, 9-15.
42. Plowright, E.E., Li, Z., Bergsagel, P.L., Chesi, M., Barber, D.L., Branch, D.R., Hawley, R.G. and Stewart, A.K. (2000) Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis. Blood, 95, 992-998.
43. Goriely, A., Hansen, R.M., Taylor, I.B., Olesen, I.A., Jacobsen, G.K., McGowan, S.J., Pfeifer, S.P., McVean, G.A., Meyts, E.R. and Wilkie, A.O. (2009) Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors. Nat. Genet., 41, 1247-1252.
44. Tomlinson, D.C., Baldo, O., Harnden, P. and Knowles, M.A. (2007) FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer. J. Pathol., 213, 91-98.
45. Iwata, T., Chen, L., Li, C., Ovchinnikov, D.A., Behringer, R.R., Francomano, C.A. and Deng, C.X. (2000) A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. Hum. Mol. Genet., 9, 1603-1613.
46. Horton, W.A., Hall, J.G. and Hecht, J.T. (2007) Achondroplasia. Lancet, 370, 162-172.
47. Passos-Bueno, M.R., Wilcox, W.R., Jabs, E.W., Sertie, A.L., Alonso, L.G. and Kitoh, H. (1999) Clinical spectrum of fibroblast growth factor receptor mutations. Hum. Mutat., 14, 115-125.
48. Naski, M.C., Wang, Q., Xu, J. and Ornitz, D.M. (1996) Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat. Genet., 13, 233-237.
49. Toydemir, R.M., Brassington, A.E., Bayrak-Toydemir, P., Krakowiak, P.A., Jorde, L.B., Whitby, F.G., Longo, N., Viskochil, D.H., Carey, J.C. and Bamshad, M.J. (2006) A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome. Am. J. Hum. Genet., 79, 935-941.
50. Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A. and Leder, P. (1996) Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell, 84, 911-921.
51. Eswarakumar, V.P. and Schlessinger, J. (2007) Skeletal overgrowth is mediated by deficiency in a specific isoform of fibroblast growth factor receptor 3. Proc. Natl Acad. Sci. USA, 104, 3937-3942.
52. Ross, J.L., Scott, C. Jr, Marttila, P., Kowal, K., Nass, A., Papenhausen, P., Abboudi, J., Osterman, L., Kushner, H., Carter, P. et al. (2001) Phenotypes associated with SHOX deficiency. J. Clin. Endocrinol. Metab., 86, 5674-5680.
53. Pfaffl, M.W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res., 29, e45.
54. Schmidt, D., Wilson, M.D., Spyrou, C., Brown, G.D., Hadfield, J. and Odom, D.T. (2009) ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions. Methods, 48, 240-248.
55. Lee, T.I., Johnstone, S.E. and Young, R.A. (2006) Chromatin immunoprecipitation and microarray-based analysis of protein location. Nat. Protoc., 1, 729-748.
56. Langmead, B., Trapnell, C., Pop, M. and Salzberg, S.L. (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol., 10, R25.
57. Zhang, Y., Liu, T., Meyer, C.A., Eeckhoute, J., Johnson, D.S., Bernstein, B.E., Nusbaum, C., Myers, R.M., Brown, M., Li, W. et al. (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol., 9, R137.